C
EWTX icon

Covestor’s Edgewise Therapeutics EWTX Stock Holding History

Covestor’s Portfolio EWTX Stock Details EWTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1K Buy
21
+13
+163% +$448 ﹤0.01% 2141
2026
Q1 		$0 Hold
8
– – ﹤0.01% 2407
2025
Q4 		$0 Hold
8
– – ﹤0.01% 2393
2025
Q3 		$0 Hold
8
– – ﹤0.01% 2422
2025
Q2 		$0 Buy
8
+3
+60% +$43 ﹤0.01% 2360
2025
Q1 		$0 Hold
5
– – ﹤0.01% 2373
2024
Q4 		$0 Sell
5
-2
-29% -$64 ﹤0.01% 2382
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2368
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2382
2024
Q1 		$0 Buy
+7
New +$111 ﹤0.01% 2379

Other funds holding EWTX

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.72B AUM 106.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Covestor's EWTX Position: Q2 2026 in Review

Covestor increased its Edgewise Therapeutics (EWTX) stake by 163% in Q2 2026, buying an estimated $448 and bringing the position to 21 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #2141.

Covestor first reported a position in EWTX in Q1 2024 and has held it in 10 quarters since. 226 funds tracked by Wall St. Rank hold EWTX as of Q2 2026.

  • Covestor held 21 shares of Edgewise Therapeutics worth $1K as of Q2 2026.
  • Covestor bought 13 Edgewise Therapeutics shares in Q2 2026, an estimated $448.
  • Edgewise Therapeutics made up ﹤0.01% of Covestor's portfolio in Q2 2026, its #2141 holding.
  • Covestor first reported a position in Edgewise Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • 226 funds tracked by Wall St. Rank held Edgewise Therapeutics as of Q2 2026.

Based on Covestor's 13F filing for Q2 2026, filed 7 Aug 2026.